同日磁共振引导单次立体定向放疗治疗非脊柱骨转移疼痛的单中心研究
BONE SHOT 研究前瞻性纳入 13 例伴疼痛性非脊柱骨转移的实体瘤患者(15 个病灶),在同日完成磁共振引导下计划与单次立体定向放疗(SF-SBRT)。所有流程按计划完成,中位在床时间 65 分钟,未记录 ≥3 级毒性;4 周时总体疼痛缓解率 66.7%、完全缓解率 53.3%,疼痛评分中位下降 5 分(P = 0.0028)。
要点
- 同日 MR 引导单次 SBRT 流程可行,中位在床时间 65 分钟。
- 治疗耐受良好,无 ≥3 级毒性,仅 1 例出现疼痛闪烁。
- 4 周总体疼痛缓解率 66.7%,完全缓解率 53.3%。
核心结论
- 同日磁共振引导单次立体定向放疗治疗非脊柱骨转移疼痛可行、安全,初步疗效值得进一步试验。
研究设计与样本
- 前瞻性单中心研究,纳入疼痛评分≥3/10 且影像学确认的实体瘤非脊柱骨转移患者,共 13 例 15 个病灶。
- 患者接受 MR-Linac(ViewRay®)同日咨询、知情同意、计划与单次 SBRT 治疗,记录退出率、流程时间、急性毒性和疼痛反应。
主要发现
- 2019 年 6 月至 2020 年 6 月共治疗 13 例患者 15 个病灶,平均年龄 64 岁(范围 30–87),最常见原发肿瘤为消化道恶性肿瘤(38.5%),最常见治疗部位为骨盆(53.3%)。
- 所有流程按计划完成,勾画、计划和实施的中位在床时间为 65 分钟(范围 57–112)。
- 治疗耐受良好,1 例出现疼痛闪烁,未记录 ≥3 级毒性。
- SBRT 后 1 周总体疼痛缓解率和完全缓解率分别为 73.3% 和 20.0%,4 周时分别为 66.7% 和 53.3%。
- 治疗前中位疼痛评分为 6 分,4 周时中位下降 5 分(P = 0.0028)。
临床怎么用
- 对于疼痛性非脊柱骨转移患者,可考虑同日完成 MR 引导单次 SBRT 的流程,以缩短就诊环节。
- 治疗前疼痛评分≥3/10 且影像学确认的非脊柱骨转移为研究中纳入条件。
局限性
- 单中心、小样本(13 例 15 个病灶)前瞻性研究,结果需未来试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION AND BACKGROUND: There is evidence for efficacy of high-dose single-fraction stereotactic body radiotherapy (SF-SBRT) for painful non-spine bone metastases (NSBMs). This study ("BONE SHOT") assessed feasibility of same-day magnetic resonance-guided (MRg) planning and SF-SBRT delivery, recorded toxicity and assessed efficacy for treating metastatic patients with NSBMs. MATERIALS AND METHODS: Patients with painful (≥3/10 points on a 0-10 numeric rating scale (NRS) for pain) and radiologically confirmed NSBMs from solid organ malignancies were eligible for this prospectively acquired, single-center study. Patients received MRg-SF-SBRT via MR-Linac (ViewRay®) with same-day consultation, consent, planning and treatment. Drop-out rate, procedure times, acute toxicity and pain response were recorded. RESULTS: Between June 2019 and June 2020, 13 patients with 15 NSBMs were treated per protocol. Mean patient age was 64 (range, 30-87) years; most common primary cancer was gastrointestinal malignancies (38.5 %); most commonly treated site was pelvis (53.3 %). All workflows were completed as planned. Median on-table time for contouring, planning and delivery was 65 (range, 57-112) minutes. Treatments were well tolerated; one patient developed "pain flair"; no grade ≥ 3 toxicities were registered. At one week following SBRT, overall and complete pain response rates were 73.3 % and 20.0 %, respectively, which evolved to 66.7 % and 53.3 % at four weeks after SBRT; median pre-treatment pain score was 6 points, which was reduced by a median of 5 points (P = 0.0028) at four weeks. CONCLUSION: The same-day MRg-SF-SBRT workflow for NSBMs was feasible, safe, and preliminary results indicate promising efficacy, warranting future trials investigating this intervention.
引用
- Christ SM, Kretschmer EM, Mayinger M, et al. Same-Day Magnetic Resonance-Guided Single-Fraction Stereotactic Body Radiation Therapy for Painful Non-Spine Bone Metastases - A Single-Center Study ("BONE SHOT"). Clin Transl Radiat Oncol. 2025. PMID: 40438564. doi:10.1016/j.ctro.2025.100966
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。